Novo Nordisk A/S is arguing before the Third Circuit that the Medicare agency unlawfully selected six of its insulin products ...

Recent data reveals that the eurozone economy has narrowly skirted a recession, showing lukewarm yet positive growth. With ...

Scientists have designed a new form of insulin that can automatically switch itself on and off depending on glucose levels in ...

Eighty states, cities, counties, school boards and unions have joined litigation in a New Jersey district court against the three major pharmacy middlemen.

Despite uncertainty around who will sit in The White House in January and what ramifications they may bring, the industry’s ...

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third ...

Hims stock has rallied almost 22% this week on enthusiasm after the FDA said it will allow compounded versions of Lilly's ...

The case for Novo Nordisk. Right now Novo Nordisk has a considerable lead on Lilly in GLP-1 market share, and a couple of ...

The UK Government is considering using weight-loss drugs to help support obese people in returning to work and reduce the high rates of long-term sickness, which have become a significant strain on ...

The Team Novo Nordisk Ambassador was diagnosed with type 1 diabetes at the age of 12, but that didn't stop him from winning medals at the European and World championships: "Through my own journey, I ...

Weight loss drugs such as Wegovy have risen in popularity in recent months - but how exactly does it work and what are the side effects?

Wegovy, produced by Danish drugmaker Novo Nordisk, made a debut here on Tuesday, 16 months after the drug obtained regulatory ...